{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:54:29Z","timestamp":1788990869484,"version":"build-2803163510"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The availability of direct-acting antiviral (DAA) therapy might have impacted use of hepatitis C virus (HCV)-infected (HCV+) deceased donor kidneys for transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used 2005 to 2018 Scientific Registry of Transplant Recipients data to identify 18 936 candidates willing to accept HCV+ kidneys and 3348 HCV+ recipients of HCV+ kidneys. We compared willingness to accept, utilization, discard, and posttransplant outcomes associated with HCV+ kidneys between 2 treatment eras (interferon [IFN] era, January 1, 2005 to December 5, 2013 vs DAA era, December 6, 2013 to August 2, 2018). Models were adjusted for candidate, recipient, and donor factors where appropriate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the DAA era, candidates were 2.2 times more likely to list as willing to accept HCV+ kidneys (adjusted odds ratio,<jats:sub>2.07<\/jats:sub>2.23<jats:sub>2.41<\/jats:sub>;<jats:italic toggle=\"yes\">P<\/jats:italic>&lt; 0.001), and HCV+ recipients were 1.95 times more likely to have received an HCV+ kidney (adjusted odds ratio,<jats:sub>1.76<\/jats:sub>1.95<jats:sub>2.16<\/jats:sub>;<jats:italic toggle=\"yes\">P<\/jats:italic>&lt; 0.001). Median Kidney Donor Profile Index of HCV+ kidneys decreased from 77 (interquartile range [IQR], 59-90) in 2005 to 53 (IQR, 40-67) in 2017. Kidney Donor Profile Index of HCV\u2212 kidneys remained unchanged from 45 (IQR, 21-74) to 47 (IQR, 24-73). After adjustment, HCV+ kidneys were 3.7 times more likely to be discarded than HCV\u2212 kidneys in the DAA era (adjusted relative rate,<jats:sub>3.36<\/jats:sub>3.67<jats:sub>4.02<\/jats:sub>;<jats:italic toggle=\"yes\">P<\/jats:italic>&lt; 0.001); an increase from the IFN era (adjusted relative rate,<jats:sub>2.78<\/jats:sub>3.02<jats:sub>3.27<\/jats:sub>;<jats:italic toggle=\"yes\">P<\/jats:italic>&lt; 0.001). HCV+ kidney use was concentrated within a subset of centers; 22.5% of centers performed 75% of all HCV+ kidney transplants in the DAA era. Mortality risk associated with HCV+ kidneys remained unchanged (aHR,<jats:sub>1.07<\/jats:sub>1.19<jats:sub>1.32<\/jats:sub>in both eras).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Given the elevated risk of death on dialysis facing HCV+ candidates, improving quality of HCV+ kidneys, and DAA availability, broader utilization of HCV+ kidneys is warranted to improve access in this era of organ shortage.<\/jats:p><\/jats:sec>","DOI":"10.1097\/tp.0000000000002323","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:53:05Z","timestamp":1529023985000},"page":"2088-2095","source":"Crossref","is-referenced-by-count":38,"title":["Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy"],"prefix":"10.1097","volume":"102","author":[{"given":"Mary G.","family":"Bowring","sequence":"first","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Kucirka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan B.","family":"Massie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveen","family":"Ishaque","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunjae","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashton A.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Garonzik Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sulkowski","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorry L.","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Durand","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS","volume":"65","year":"2004","journal-title":"Kidney Int"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0272-6386(05)80024-1","article-title":"Hepatitis C virus transmission in the hemodialysis community","volume":"37","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/ajkd.2001.25199","article-title":"Hepatitis C screening strategies in hemodialysis patients","volume":"38","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2893.2007.00853.x","article-title":"Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis","volume":"14","year":"2007","journal-title":"J Viral Hepat"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/089686080802800215","article-title":"Mortality in hepatitis C-positive patients treated with peritoneal dialysis","volume":"28","year":"2008","journal-title":"Perit Dial Int"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1681\/ASN.2006070736","article-title":"Hepatitis C virus and death risk in hemodialysis patients","volume":"18","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-6143.2004.00652.x","article-title":"Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list","volume":"5","year":"2005","journal-title":"Am J Transplant"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1001\/jama.294.21.2726","article-title":"Deceased-donor characteristics and the survival benefit of kidney transplantation","volume":"294","year":"2005","journal-title":"JAMA"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1111\/ajt.12830","article-title":"Survival benefit of primary deceased donor transplantation with high-KDPI kidneys","volume":"14","year":"2014","journal-title":"Am J Transplant"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1681\/ASN.2010060668","article-title":"Effect of kidney transplantation on outcomes among patients with hepatitis C","volume":"22","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1600-6143.2004.00606.x","article-title":"The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1007\/s00268-012-1748-0","article-title":"The faltering solid organ donor pool in the United States (2001-2010)","volume":"36","year":"2012","journal-title":"World J Surg"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/ckj\/sfx048","article-title":"Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes","volume":"10","year":"2017","journal-title":"Clin Kidney J"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1600-6143.2010.03091.x","article-title":"Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0272-6386(97)90345-0","article-title":"The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients","volume":"29","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1399-0012.2004.00252.x","article-title":"Renal transplantation offers a better survival in HCV-infected ESRD patients","volume":"18","year":"2004","journal-title":"Clin Transplant"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/TP.0000000000000479","article-title":"Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts","volume":"99","year":"2015","journal-title":"Transplantation"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/j.1600-6143.2006.01374.x","article-title":"Acute renal allograft rejection following pegylated IFN-alpha treatment for chronic HCV in a repeat allograft recipient on hemodialysis: a case report","volume":"6","year":"2006","journal-title":"Am J Transplant"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00007890-199801150-00026","article-title":"A 20-year case study of a kidney transplant recipient with chronic active hepatitis C: clinical course and successful treatment for late acute rejection induced by interferon therapy","volume":"65","year":"1998","journal-title":"Transplantation"},{"key":"bib20-20231002","first-page":"1043","article-title":"Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts","volume":"23","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(15)00349-9","article-title":"Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/M16-1205","article-title":"Treatment with ledipasvir-sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: a randomized Trial","volume":"166","year":"2017","journal-title":"Ann Intern Med"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2016.12.020","article-title":"Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"e7568","DOI":"10.1097\/MD.0000000000007568","article-title":"Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: a PRISMA-compliant study","volume":"96","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"e0158431","DOI":"10.1371\/journal.pone.0158431","article-title":"Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection","volume":"11","year":"2016","journal-title":"PLoS One"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1097\/TP.0000000000000847","article-title":"Novel hepatitis C treatment and the impact on kidney transplantation","volume":"99","year":"2015","journal-title":"Transplantation"},{"key":"bib28-20231002","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/sdi.12456","article-title":"Direct-acting antiviral agents for the hepatitis C virus-infected chronic kidney disease population: the dawn of a new era","volume":"29","year":"2016","journal-title":"Semin Dial"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.kint.2017.09.002","article-title":"Expanding the use of hepatitis C-viremic kidney donors","volume":"92","year":"2017","journal-title":"Kidney Int"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/TP.0000000000000435","article-title":"Kidney transplantation threshold in patients with hepatitis C: a decision analysis model","volume":"99","year":"2015","journal-title":"Transplantation"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ajt.13976","article-title":"Changes in utilization and discard of hepatitis C-infected donor livers in the recent era","volume":"17","year":"2017","journal-title":"Am J Transplant"},{"key":"bib32-20231002","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1111\/ajt.13971","article-title":"Improving organ utilization to help overcome the tragedies of the opioid epidemic","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"bib33-20231002","doi-asserted-by":"crossref","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study","volume":"168","year":"2018","journal-title":"Ann Intern Med"},{"key":"bib34-20231002","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/ajt.12777","article-title":"Big data in organ transplantation: registries and administrative claims","volume":"14","year":"2014","journal-title":"Am J Transplant"},{"key":"bib35-20231002","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1600-6143.2010.03163.x","article-title":"Improving distribution efficiency of hard-to-place deceased donor kidneys: predicting probability of discard or delay","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"bib36-20231002","first-page":"1","article-title":"Effective communication of standard errors and confidence intervals","volume":"10","year":"2009","journal-title":"Biostatistics"},{"key":"bib37-20231002","article-title":"Impact of willingness to accept hepatitis c seropositive kidneys among hepatitis C RNA-positive waitlisted patients","journal-title":"Transplantation"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1111\/j.1600-6143.2010.03294.x","article-title":"Center-level patterns of indicated willingness to and actual acceptance of marginal kidneys","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2010.03280.x","article-title":"Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"bib40-20231002","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1097\/TP.0000000000001238","article-title":"Predictors of deceased donor kidney discard in the United States","volume":"101","year":"2017","journal-title":"Transplantation"},{"key":"bib41-20231002","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2215\/CJN.07190715","article-title":"Epidemiology of kidney discard from expanded criteria donors undergoing donation after circulatory death","volume":"11","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"bib42-20231002","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMp1505074","article-title":"Transplanting hepatitis C-positive kidneys","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"bib43-20231002","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1600-6143.2010.03329.x","article-title":"Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib44-20231002","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/TP.0000000000001953","article-title":"Long-term Patient and graft survival of kidney transplant recipients with hepatitis C virus infection in the United States","volume":"102","year":"2018","journal-title":"Transplantation"},{"key":"bib45-20231002","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/ajt.14577","article-title":"Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys","volume":"18","year":"2018","journal-title":"Am J Transplant"},{"issue":"suppl 3","key":"bib46-20231002","article-title":"EXPANDER-1: exploring renal transplants using hepatitis-C infected donors for HCV-negative recipients. [abstract]","volume":"17","year":"2017","journal-title":"Am J Transplant"},{"key":"bib47-20231002","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","year":"2017","journal-title":"N Engl J Med"},{"key":"bib48-20231002","article-title":"The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes","year":"2018","journal-title":"Am J Transplant"},{"key":"bib49-20231002","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/TP.0000000000002033","article-title":"Use of organs from hepatitis C virus-positive donors for uninfected recipients: a potential cost-effective approach to save lives?","volume":"102","year":"2018","journal-title":"Transplantation"},{"key":"bib50-20231002","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/TP.0000000000002032","article-title":"Expanding the use of organs from hepatitis C-viremic donors: the evidence continues to build","volume":"102","year":"2018","journal-title":"Transplantation"},{"key":"bib51-20231002","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1111\/ajt.14386","article-title":"Utilization of organs from donors according to hepatitis C antibody and nucleic acid testing status: time for change","volume":"17","year":"2017","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201812000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T13:49:39Z","timestamp":1720360179000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201812000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002323","relation":{},"ISSN":["1534-6080","0041-1337"],"issn-type":[{"value":"1534-6080","type":"electronic"},{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}